Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Abcam PLC Sponsored ADR (ABCM). But which of these two stocks offers value inves

Globus Medical: Almost Having My Back

03:49pm, Wednesday, 13'th Sep 2023
Globus Medical, Inc. shares have seen a significant pullback after announcing a $3 billion deal to acquire NuVasive. The company has a strong track record in the spine industry and has been outgrowing
Globus Medical's (GMED) Precice Bone Transport is a less intrusive treatment that reduces complications for both the patient and the surgeon and is designed for various bone abnormalities.
Globus Medical's (GMED) recent deal combines complementary spine and orthopedic solutions, enabling technologies to create one of the industry's most comprehensive, innovative offerings.
According to Globus Medical (GMED), the increase in R&D expenses is largely focused on Spine and Enabling Technologies.
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street es
Globus Medical (GMED) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.60 per share. This compares to earnings of $0.56 per share a year ago.
Globus Medical's (GMED) Enabling technology sales improvement is driven by strong performance of its robotic and imaging system.
Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Globus Medical (GMED). But which of these two stocks is more attractive to value invest
Globus Medical's Q1 sales grew by 21% YoY to a record $277m, driven by robust musculoskeletal sales and demand for its robotics offerings. The company's merger with NuVasive, initially met with invest
AUDUBON, Pa., July 13, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30,
Globus Medical (GMED) continues to make significant progress in launching its prone lateral patient positioning system.
Investors continue to be optimistic about Globus Medical (GMED) based on the strong performances across geographies and the pending NuVasive acquisition.
Globus Medical's (GMED) REFLECT is intended to treat young children with progressive scoliosis, while preserving motion, stability and future modulated growth.
The significant year-over-year surge in Globus Medical's (GMED) Enabling Technologies sales is driven by ongoing demand for the company's robotics and imaging system technologies.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE